Pfizer is an American, multinational pharmaceutical and biotechnology corporation. The company was founded in 1849, in New York, New York, United States.
Pfizer has the mission to fund programs that provide public benefit, advance medical care, and can improve patient outcomes. Their researchers preform 25,000 clinical tests everyday for pharmaceutical development and innovations.
Pfizer is a partner with the BaseLaunch startup accelerator. The BaseLaunch program receives applications in the fields of therapeutics, diagnostics, digital healthcare, healthcare services, therapeutic platforms, and medical technology.
Insilico Medicine and Pfizer entered into a research collaboration agreement. The agreement allows Pfizer to utilize Insilico Medicine's machine learning technology and Pandomics Discovery Platform to research potential therapeutic targets for a variety of diseases.
AMRA Medical and Pfizer's partnership works to investigate body fat distribution and muscle composition in a range of diseases using the UK Biobank registry. The partnership involves the body composition analysis of 100,000 individuals.
Pfizer's partnership with CytoReason gives them access to CytoReason's machine learning platform for drug discovery and development.
XtalPi Inc. and Pfizer's research collaboration focuses on developing a hybrid physics-and artificial intelligence-powered software platform for accurate molecular modeling of small molecules. The platform is intended to advance both companies capabilities in drug design and solid-form selection.
Pfizer and Distributed Bio entered an agreement to license Distributed Bio's SuperHuman Platform to Pfizer. The SuperHuman 2.0 antibody discovery platform will allow Pfizer to utilize the antibody library for screening activities against Pfizer-selected targets.
Domain Therapeutics and Pfizer entered into a collaboration agreement to asses Domain Therapeutics's bioSensAll platform. The bioSensAll platform defines signaling signatures for each wild-type and mutant receptors. Pfizer aims to use the platform to assess the impact of mutations on different signaling pathways engaged by g protein-coupled receptors.
Pfizer announced that they have identified certain anti-viral compounds that are under development which could be effective in treating the novel coronavirus SARS-CoV-2 responsible for COVID-19. They may enter a partnership with a third party company to screen and identify potential compounds by the end of March, 2020 in order to begin testing in April, 2020.
Pfizer is partnered with BioNTech for co-development and distribution of an mRNA vaccine against SARS-CoV-2 called BNT162.
Timeline
The first-quarter revenues for the vaccine account for $3.5 billion of total revenues of $14.6 billion.
Although not explicitly addressed in the first-quarter announcement, the company expects the FDA to authorize the Pfizer-BioNTech COVID-19 vaccine within the week for adolescents ages 12 and older.
The European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.
Acquisitions
People
A. Santiesteban
Employee
Abby Michaud
Employee
Abdalrahman Mekky, CMA
Employee
Abinaya A
Employee
Abiola Joseph
Employee
Abraham Svinkelstin, PMP, MS, MS, CSSGB
Employee
Adam Escalante
Employee
Adekunle Adeniran
Employee
Agnes Lei
Employee
AHMET ADIYAMAN
Employee
Aimee Greene
Employee
Aindréas MacDomhnaill
Employee
Aine Aherne
Employee
Akanqsha Shetty
Employee
Alba Hernandez
Employee
Alec Robert Gilarde
Employee
Alejandra Fonseca
Employee
Alekhya Reddy
Employee
Alex Haddad
Employee
Alexander H. Buell
Employee
Alexandra Grossbarth
Employee
Alexey Chapyshev
Employee
Alican Liceoglu
Employee
Alisha Dhiman
Employee
Alison Hanlon
Employee
Further reading
Breaking the Rules of Biology to Beat Rare Genetic Disease | Pfizer
Web
Pfizer's Core Values of Social Responsibility and Philanthropy | Pfizer
Web
What to Know About Coronavirus -- COVID-19 Explained | Pfizer
Web
Documentaries, videos and podcasts
Companies
Pfizer
Alberta Bourla
New York, New York, United States
Medical, healthcare, biotechnology, and pharmaceutical products and services
News
References
Company attributes
Venture Capital Firm attributes
Other attributes
Categories
Related Topics
Contributors
- 1
Aleksander Holm
Interested in understanding the world we live in. - 2
Daniel Frumkin
Mechanical engineering, cryptocurrencies, AI, and travel. - 3
Aime Anne Nisay
QA Engineer of web and mobile applications - 4
Henry Ogolla
Passionate about reading and writing. - 5
Holden Page
Organizing information sporadically - 6
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 7
Jason D. Rowley
Former Data Acquisition Lead @ Golden (Recursion Inc.). Excited about open knowledge and pulling the future forward. - 8
Melanie Manipula
Helping organize knowledge. - 9
Julius John Villarisco
Every day is a new learning for me, new opportunity every time. Never limit my self, think outside the box. - 10
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME
